Revised forecast
Fiscal year ending March 2027 · Six months and full yearThe bar length represents the relative magnitude of change, based on the item that changed the most in this document.
Because the effects of initiatives to address management issues are expected to be limited.
Product defect remediation costs of ¥40.227 million, impairment losses of ¥1.361 million, loss on sale of fixed assets of ¥0.467 million, and loss on disposal of fixed assets of ¥1.296 million, for total extraordinary losses of ¥43.352 million.
| Item | Details |
|---|---|
| Net Sales | Not disclosed → Cumulative second-quarter results 6,800 / Full year 13,600 |
| Operating profit | Not disclosed → Cumulative second-quarter results 80 / Full year 230 |
| Ordinary income | Not disclosed → Cumulative second-quarter results 100 / Full year 250 |
| Profit attributable to owners of the parent | Not disclosed → Cumulative second-quarter results 50 / Full year 120 |
| Net income per share | Not disclosed → Cumulative second-quarter results 6.88 / Full year 16.51 |
| Fiscal Period Covered | Fiscal year ending March 2027 |
| Period Covered | Six months and full year |
| Previous-period results | Net sales of ¥12,857 million, operating profit of ¥284 million, ordinary profit of ¥384 million, profit attributable to owners of parent of ¥210 million, and earnings per share of ¥28.92 (fiscal year ended March 2026) |
| Reason for the revision | Because the effects of initiatives to address management issues are expected to be limited. |
| Details and amount of extraordinary loss | Product defect remediation costs of ¥40.227 million, impairment losses of ¥1.361 million, loss on sale of fixed assets of ¥0.467 million, and loss on disposal of fixed assets of ¥1.296 million, for total extraordinary losses of ¥43.352 million. |
| Dividend forecast revision | For the fiscal year ending March 2027, the dividend forecast is ¥40.00 per share at the end of the second quarter and ¥40.00 per share at the fiscal year-end, for an annual dividend of ¥80.00. Change: Not disclosed. |
| Consolidated / non-consolidated | Consolidated |
Items this document does not state (1)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.For the fiscal year ended March 2026, profit was weighed down by higher raw material prices, delays in the start of mass production at the Chinese factory, increased R&D investment in new products and technologies, and higher depreciation and selling, general and administrative expenses associated with the new domestic site and Chinese factory. For the fiscal year ending March 2027, the company expects the effects of its initiatives to address management issues to be limited.